Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Jim Cramer Broke Down 5 Stocks Including Pharma Plays for Rising Oil

In this article, we will look at “Jim Cramer Broke Down 5 Stocks Including Pharma Plays for Rising Oil”. Please visit Jim Cramer Broke Down 16 Stocks Including Pharma Plays for Rising Oil, if you’d like to see the extended list and methodology behind it.

5. Pfizer Inc. (NYSE:PFE)

Jim Cramer reviewed Pfizer Inc. (NYSE:PFE) while breaking down 16 stocks for a market facing higher energy costs and economic uncertainty. Cramer mentioned the stock during the episode and said:

In a slowdown, the hedge fund playbook says you want safety stocks. The stocks of companies that will make good money even if the broader economy deteriorates dramatically, the opposite of cyclical stocks. For example, big pharma. Now, if you need a medication, you’ll keep taking it in good times and bad. You don’t skip a dose. This is textbook recession-proof… And within big pharma, Lang likes Pfizer, Merck, and Bristol-Myers, three stocks with strong dividend yields that are seeing substantial institutional buying right now. I like all three, by the way. Let’s start with the daily chart of Pfizer, right, which Lang says is his favorite in the group.

Lately, he points out that Pfizer has had strong volume trends, meaning the stock tends to rally on high volume… By the way, when it declines, it’s usually on lower volume… For technicians, volume is like a polygraph… High volume on up days and lower volume on down days mean you’ve got an honest uptrend on your hands. Pfizer also has made a series of higher highs and higher lows… But this is textbook. It’s exactly how you want to see it. The stock remains above its 50-day moving average…

These are all bullish readings. Plus, the stock’s made a bullish cup and handle… This is one of the most reliably positive formations out there. Very encouraging… Take a look at the Chaikin Money Flow. Alright, this is an indicator that shows you whether big institutions are buying or selling. It spent most of this year in bullish territory, which tells us that institutional money managers are eagerly buying Pfizer here. At the same time, Lang likes that Pfizer pays you a bountiful 6.3% dividend yield. Now, I’m debating talking about Pfizer at our club meeting… but everything says fine. I just need to know their product flow better.

Pfizer Inc. (NYSE:PFE) develops and sells medicines and vaccines for several health conditions, including heart disease, infections, COVID-19, and rare diseases. The company was part of our list of the best undervalued stocks under $50 to invest in. You can read more here.

4. Generac Holdings Inc. (NYSE:GNRC)

Jim Cramer reviewed Generac Holdings Inc. (NYSE:GNRC) while breaking down 16 stocks for a market facing higher energy costs and economic uncertainty. Cramer explained why the stock recently sold off, as he commented:

Today, one of our favorites, Generac Holdings, the maker of backup power generators for both housing and the data center, held an investor meeting. At first glance, Wall Street, I don’t know, a little cool. Even though management said that their data center backlog has surged 75% over just the last 6 weeks, they didn’t announce a new long-term contract with a big hyperscaler. Maybe that’s what the hedge funds were looking for. You can never please those guys. That’s why the stock initially sold off 10% today before rebounding, finishing the session off less than 2%. It may sound like Generac’s being held to a ridiculously high standard, but this is a stock that’s up over 50% year to date. We don’t have a lot of those.

Generac Holdings Inc. (NYSE:GNRC) manufactures and distributes energy technology products, including residential and industrial generators, battery storage systems, smart home solutions, and outdoor power equipment.

3. NIKE, Inc. (NYSE:NKE)

Jim Cramer reviewed NIKE, Inc. (NYSE:NKE) while breaking down 16 stocks for a market facing higher energy costs and economic uncertainty. A caller asked if the stock is a buy right now, and Cramer replied:

Okay, so, this is, whoa, this is one that, so far, I’ve done some, a couple of them lately that have been unbelievable, and a couple of them lately that have not been that good. It’s okay to admit that because I’ve never heard anyone else on TV ever say it, and Nike is one of them. I am growing impatient, but I’m not giving up because I still, it’s a huge turn, and I do think if I’m patient, I think we’ll see $70 for that stock. So, I’m not selling it. I’m going to talk about that on Friday, but people are getting bored with me beating myself up. But that’s what I, that’s kind of how I am.

NIKE, Inc. (NYSE:NKE) is an athletic and casual footwear, apparel, equipment, and accessories company that sells its products under brands, including Nike, Jordan, and Converse. A caller inquired about the stock during the February 27 episode, and Cramer responded:

Okay, so I would tell you, let’s say… we brought Elliott Hill here. He would say that the number one thing we have to improve on is quality. He would totally agree with you. The problem is, I think that they got run down, and you can’t turn around a fashion play in two, three, four, or maybe even five quarters. We have to wait a full maybe year, maybe two years, to see what he does. That’s how poorly the company was doing that he received, and he’s doing his best. The Charitable Trust owns it. Right now, it’s disappointing, but I’m betting that with more time, it will not be disappointing. That’s all I can tell you.

2. CME Group Inc. (NASDAQ:CME)

Jim Cramer reviewed CME Group Inc. (NASDAQ:CME) while breaking down 16 stocks for a market facing higher energy costs and economic uncertainty. When a caller asked about the stock during Mad Money, Cramer said:

No, I worked at Goldman. Why not get a piece of action by working at Goldman or buying the stock in Goldman Sachs, which does incredibly well in this turmoil? This is exactly the kind of market that we did well at Goldman. And I say we, I know I’m an alumnist… When I say Goldman, I did play for Goldman.

CME Group Inc. (NASDAQ:CME) operates global marketplaces for trading futures and options across a number of asset classes, including interest rates, equities, currencies, and commodities. Pelican Bay Capital Management stated the following regarding CME Group Inc. (NASDAQ:CME) in its fourth quarter 2025 investor letter:

In addition to the trading activity we discussed above, we also made the decision to exit our positions in CME Group Inc. (NASDAQ:CME) and ON Semiconductor (ON). Additionally, while CME is a great company and has been an excellent investment for our portfolio, it was at the high end of fair value, and we needed to make room for a new position as the portfolio was at out 20 stock holdings limit.

1. Roblox Corporation (NYSE:RBLX)

Jim Cramer reviewed Roblox Corporation (NYSE:RBLX) while breaking down 16 stocks for a market facing higher energy costs and economic uncertainty. Inquiring about the stock, a caller noted that although it is down, the younger generation seems to love it. Cramer replied:

You know, this is a stock that every time you try to call it and think it’s going to turn and go up because it makes great entertainment products, it lets you down. So, here’s what I’m going to say to you: Don’t own it, okay? It’s just not, it’s too hard. Some stocks, by the way, are too hard. That’s just the way it is. You say to yourself, “Hey, you know, I’m thinking about buying this for the Charitable Trust.” No, it’s too hard.

Roblox Corporation (NYSE:RBLX) runs an online platform where users can play, create, and share interactive 3D experiences. During the January 7 episode, a caller mentioned that they were considering the stock as a speculative play and asked for Cramer’s advice. The Mad Money host responded:

Okay, now, this company is a very, very good company that people decided to pay too much for. In other words, because it’s losing money, this market no longer wants it. Remember what I said, last year was the year of magical investing. That year’s over. If you’re losing money, people don’t want to touch it. That said, Dave Baszucki does a good job running it. I wouldn’t mind a speculative position only on Roblox.

While we acknowledge the potential of RBLX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than RBLX and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading Into 2026 and 15 Stocks That Will Make You Rich in 10 Years. 

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.